Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Clodronic-acid | hsa00010 | Glycolysis / Gluconeogenesis | 2.17E-02 | 3 | P04075, P04406, P60174 | ALDOA, GAPDH, TPI1 | More | | Clodronic-acid | hsa00020 | Citrate cycle (TCA cycle) | 3.65E-02 | 2 | O75390, P40926 | CS, MDH2 | More | | Clodronic-acid | hsa00051 | Fructose and mannose metabolism | 2.48E-02 | 2 | P60174, P04075 | TPI1, ALDOA | More | | Clodronic-acid | hsa01200 | Carbon metabolism | 1.20E-02 | 4 | P04075, P04406, P60174, P40926 | ALDOA, GAPDH, TPI1, MDH2 | More | | Clodronic-acid | hsa01230 | Biosynthesis of amino acids | 1.28E-02 | 3 | P60174, P04406, P04075 | TPI1, GAPDH, ALDOA | More | | Clodronic-acid | hsa03010 | Ribosome | 7.17E-06 | 15 | P62753, P32969, P30050, P40429, P62906, P62917, P46776, Q9H0U6, Q07020, P61513, P36578, P27635, P05386, P62249, P23396 | RPS6, RPL9, RPL12, RPL13A, RPL10A, RPL8, RPL27A, MRPL18, RPL18, RPL37A, RPL4, RPL10, RPLP1, RPS16, RPS3 | More | | Clodronic-acid | hsa03013 | RNA transport | 4.75E-02 | 6 | P62826, Q9UBU9, P63279, P68104, P11940, P20042 | RAN, NXF1, UBE2I, EEF1A1, PABPC1, EIF2S2 | More | | Clodronic-acid | hsa03030 | DNA replication | 3.59E-02 | 2 | P49005, P33993 | POLD2, MCM7 | More | | Clodronic-acid | hsa03040 | Spliceosome | 1.54E-02 | 6 | P17844, Q13435, P51991, P61978, Q15365, P11142 | DDX5, SF3B2, HNRPA3, HNRPK, PCBP1, HSPA8 | More | | Clodronic-acid | hsa04071 | Sphingolipid signaling pathway | 4.56E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Clodronic-acid | hsa04141 | Protein processing in endoplasmic reticulum | 2.71E-02 | 7 | P18848, Q15436, P11142, Q9NXW2, Q9H3Z4, Q9NR31, P14625 | ATF4, SEC23A, HSPA8, DNAJB12, DNAJC5, SAR1A, HSP90B1 | More | | Clodronic-acid | hsa04340 | Hedgehog signaling pathway | 3.46E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Clodronic-acid | hsa04612 | Antigen processing and presentation | 2.40E-02 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Clodronic-acid | hsa04613 | Neutrophil extracellular trap formation | 3.61E-02 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Clodronic-acid | hsa04621 | NOD-like receptor signaling pathway | 2.62E-02 | 11 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, DEFA4 | More | | Clodronic-acid | hsa04657 | IL-17 signaling pathway | 3.91E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Clodronic-acid | hsa04658 | Th1 and Th2 cell differentiation | 1.12E-02 | 8 | Q04759, P20963, P09693, Q16539, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, STAT4, GATA3, TBX21, HLA-DOB | More | | Clodronic-acid | hsa04660 | T cell receptor signaling pathway | 3.76E-03 | 11 | P01375, Q9UDY8, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, Q16539, P49841 | TNF, MALT1, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, MAPK14, GSK3B | More | | Clodronic-acid | hsa04714 | Thermogenesis | 4.75E-02 | 6 | Q92618, Q15418, P62753, P13073, Q7KZN9, O15239 | ZNF516, RPS6KA1, RPS6, COX4I1, COX15, NDUFA1 | More | | Clodronic-acid | hsa04920 | Adipocytokine signaling pathway | 4.87E-02 | 2 | Q15831, P20333 | STK11, TNFRSF1B | More | | Clodronic-acid | hsa05010 | Alzheimer disease | 1.31E-02 | 10 | O15239, P13073, Q00535, P01584, P18848, O15169, P67870, P05141, P28070, P43686 | NDUFA1, COX4I1, CDK5, IL1B, ATF4, AXIN1, CSNK2B, SLC25A5, PSMB4, PSMC4 | More | | Clodronic-acid | hsa05020 | Prion disease | 1.09E-02 | 10 | P01584, P46531, P11142, O15239, P13073, P18848, P05141, P28070, P43686, P67870 | IL1B, NOTCH1, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5, PSMB4, PSMC4, CSNK2B | More | | Clodronic-acid | hsa05022 | Pathways of neurodegeneration - multiple diseases | 6.24E-03 | 12 | P67870, O15239, P13073, P18848, P05141, P20333, Q00535, O15169, P01584, Q13557, P28070, P43686 | CSNK2B, NDUFA1, COX4I1, ATF4, SLC25A5, TNFRSF1B, CDK5, AXIN1, IL1B, CAMK2D, PSMB4, PSMC4 | More | | Clodronic-acid | hsa05134 | Legionellosis | 2.00E-02 | 4 | P01584, Q9NR31, P68104, P11142 | IL1B, SAR1A, EEF1A1, HSPA8 | More | | Clodronic-acid | hsa05140 | Leishmaniasis | 1.87E-02 | 7 | P13612, O75015, P13765, O60603, P01375, Q16539, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MAPK14, NCF4 | More | | Clodronic-acid | hsa05146 | Amoebiasis | 3.91E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Clodronic-acid | hsa05171 | Coronavirus disease - COVID-19 | 6.10E-05 | 15 | P01584, P23396, P62753, P62249, P40429, P62906, P36578, P62917, P32969, P27635, P30050, Q07020, P46776, P61513, P05386 | IL1B, RPS3, RPS6, RPS16, RPL13A, RPL10A, RPL4, RPL8, RPL9, RPL10, RPL12, RPL18, RPL27A, RPL37A, RPLP1 | More | | Clodronic-acid | hsa05202 | Transcriptional misregulation in cancer | 3.00E-02 | 13 | P14780, P27930, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, LYL1, GADD45A | More | | Clodronic-acid | hsa05310 | Asthma | 2.81E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Clodronic-acid | hsa05321 | Inflammatory bowel disease | 3.16E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Clodronic-acid | hsa05332 | Graft-versus-host disease | 3.46E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | |